Request Sample
Request Methodology
Description
Liver Cancer Diagnostic Market size was valued at USD 9.2 bn in 2021, It is growing at a CAGR of 7.4% from 2022-2028. Liver cancer diagnostics are the techniques used for identification and confirmation of liver cancer. Sonography, ultrasound, magnetic resonance imaging, endoscopy and bioscopy are some of the effective diagnostic techniques used in diagnosis of liver cancer. Early stage of liver cancer shows no symptom, symptoms usually appears in late stage that leads to increase patients’ volume available for liver cancer diagnosis and treatment. There are many screening and diagnostic tests are available for liver cancer diagnosis like lab test, imaging which helps to detect liver cancer at early stage it carries side effects like less precision, excessive exposure to radiation and administration of florescent substances like barium for imaging and endoscopic procedures that are leading to less compliance. In addition the cost of diagnosis is relatively higher, hence deaths caused by liver cancer ultimately passed the burden to hospitals and medical research organizations therefore medical organizations and global pharmaceutical leaders are making efforts towards development of newer techniques of diagnosis of liver cancer. Exposure to environmental chemicals like vinyl chloride, benzene, and lifestyle changes exposing people to the risk of liver cancer. According to U.S. National Cancer Institute 35,660 new cases of HCC diagnosed and 24,550 HCC deaths occurred in the U.S. in 2015. This shows the increasing demand for diagnostic and screening techniques. Big companies like Roche Diagnostic and Abbot give their cancer test products on license basis to regional and geographical partners which either distribute their product or manufacture reagent kits for their instrument and therefore this market holds immense potential for Liver Cancer Diagnostic Market growth.
